MARKET

OPORF

OPORF

Hvivo
OTCPK
0.350
NaN%
Opening 09:30 05/21 EDT
OPEN
--
PREV CLOSE
0.350
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.350
52 WEEK LOW
0.350
MARKET CAP
240.94M
P/E (TTM)
-29.9145
1D
5D
1M
3M
1Y
5Y
1D
hVIVO Showcases Integrated Early-Stage Drug Development Platform at Capital Markets Day
TipRanks · 1d ago
hVIVO Shareholders Back All Resolutions at Annual General Meeting
TipRanks · 05/13 12:41
Stifel Nicolaus Remains a Hold on Open Orphan Plc (HVO)
TipRanks · 05/07 17:05
hVIVO wins £6m influenza human challenge trial to test monoclonal antibody
TipRanks · 05/07 06:24
hVIVO Director Brendan Buckley Sells Shares Ahead of Board Exit
TipRanks · 04/24 17:17
Shore Capital Sticks to Their Buy Rating for Open Orphan Plc (HVO)
TipRanks · 04/23 03:15
hVIVO Wins Landmark Phase III Human Challenge Contract for ILiAD’s Whooping Cough Vaccine
TipRanks · 04/22 06:26
hVIVO Publishes 2025 Annual Report and Sets May AGM Date
TipRanks · 04/17 06:10
More
About OPORF
hVIVO plc is a United Kingdom-based specialist early-stage drug development contract research organization (CRO) and human challenge trials. The Company delivers end-to-end clinical development services to a diverse and expanding client base. It specializes in conducting human challenge trials across multiple infectious and respiratory indications, leveraging its quarantine facility. The Company also offers comprehensive virology and immunology laboratory services under the hLAB brand. The Company, through its subsidiary, operates an approximately 120-bed capacity across Mannheim and Kiel, providing early-phase clinical trial services, including first-in-human and proof-of-concept studies. It also offers Early Drug Development Consulting and Biometry services to the biopharma sector. The Company also provides industry-standard, temperature-controlled storage solutions for biological and clinical materials.

Webull offers hVIVO PLC stock information, including OTCPK: OPORF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPORF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPORF stock methods without spending real money on the virtual paper trading platform.